Aristotle Fund’s Dillards DDS Stock Holding History

Aristotle Fund’s Portfolio DDS Stock Details DDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-79,000	Closed	-$4.56M	–	9
2017 Q2	$4.56M	Buy	+79,000	New	+$4.18M	2.87%	11

Other funds holding DDS

ETC

Evercore Trust Company New York $34.6B AUM 25.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aristotle Fund's DDS Position: Q3 2017 in Review

Aristotle Fund sold out of Dillards (DDS) in Q3 2017, closing a stake of 79,000 shares — an estimated $4.56M sold.

Aristotle Fund first reported a position in DDS in Q2 2017 and held it in 1 quarter. The position peaked at $4.56M in Q2 2017. 188 funds tracked by Wall St. Rank hold DDS as of Q3 2017.

Aristotle Fund reported no remaining Dillards position as of Q3 2017 after selling out during the quarter.
Aristotle Fund sold 79,000 Dillards shares in Q3 2017, an estimated $4.56M.
Aristotle Fund first reported a position in Dillards in Q2 2017 and held it in 1 quarter.
Aristotle Fund's Dillards position peaked at $4.56M in Q2 2017.
188 funds tracked by Wall St. Rank held Dillards as of Q3 2017.

Based on Aristotle Fund's 13F filing for Q3 2017, filed 13 Nov 2017.